Premium
Prescription of Antiepileptics and the Risk of Road Traffic Crash
Author(s) -
Orriols Ludivine,
FoubertSamier Alexandra,
Gadegbeku Blandine,
Delorme Bernard,
Tricotel Aurore,
Philip Pierre,
Moore Nicholas,
Lagarde Emmanuel
Publication year - 2013
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.10
Subject(s) - lacosamide , medicine , medical prescription , epilepsy , emergency medicine , pediatrics , pharmacology , psychiatry
Abstract Studies assessing the impact of epilepsy and its medication on the risk of road traffic crashes have shown inconsistent results. The aim in this study was to assess this risk using French databases. Data from three French national databases were extracted and matched: the national health care insurance database, police reports, and the national police database of injurious crashes. Only antiepileptics prescribed predominantly in epilepsy were studied (phenobarbital, phenytoin, ethosuximide, valproic acid, vigabatrin, tiagabin, levitiracetam, zonisamide, and lacosamide). A case–control analysis comparing responsible and non‐responsible drivers and a case–crossover analysis were performed. Drivers (72 685) involved in an injurious crash in France between July 2005 and May 2008, were included. Drivers exposed to prescribed antiepileptic medicines (n = 251) had an increased risk of being responsible for a crash (OR 1.74 [1.29–2.34]). The association was also significant for the most severe epileptic patients (n = 99; OR = 2.20 [1.31–3.69]). Case–crossover analysis found no association between crash risk and treatment prescription. Patients with prescription of antiepileptic drugs should be cautioned about their potential risk of road traffic crash. This risk is however more likely to be related to seizures than to the effect of antiepileptic medicines.